Total medical devices industry M&A deals worth $3bn were announced globally in October 2021, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 5.6% over the previous month of $3.22bn and a drop of 40.5% when compared with the last 12-month average, which stood at $5.11bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $2.72bn. At the country level, the Canada topped the list in terms of deal value at $1.75bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of M&A deals activity in October 2021 was the US with 15 deals, followed by the China with three and France with three.
In 2021, as of October, medical devices M&A deals worth $51.62bn were announced globally, marking an increase of 28.3% year on year.
medical devices industry M&A deals in October 2021: Top deals
The top five M&A deals accounted for 87.8% of the overall value during October 2021.
The combined value of the top five medical devices M&A deals stood at $2.67bn, against the overall value of $3bn recorded for the month.
The top five medical devices industry M&A deals of October 2021 tracked by GlobalData were:
1) Boston Scientific $1.75bn acquisition deal with Baylis Medical Inc
2) The $400m acquisition of Volumetric by 3D Systems
3) Integer $220m acquisition deal with Oscor
4) The $160m acquisition of Bolder Surgical by Hologic
5) MicroPort Surgical $142.6m acquisition deal with Hemovent
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.